OCUL
Ocular Therapeutix Inc
Price:  
6.17 
USD
Volume:  
1,186,465.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OCUL Relative Valuation

-253.9%
Upside

As of 2024-05-19, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (9.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.17 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -253.9%.

The range of the Relative Valuation is (7.15) - (10.41) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 5.9x - 14.0x 9.7x
Forward P/E multiples 9.6x - 21.3x 15.8x
Fair Price (7.15) - (10.41) (9.50)
Upside -215.9% - -268.8% -253.9%
6.17 USD
Stock Price
(9.50) USD
Fair Price

OCUL Relative Valuation - Historical P/E Data

Date P/E
2024-05-17 -8.28
2024-05-16 -8.42
2024-05-15 -8.44
2024-05-14 -8.12
2024-05-13 -7.57
2024-05-10 -7.60
2024-05-09 -7.84
2024-05-08 -7.72
2024-05-07 -7.96
2024-05-06 -7.79
2024-05-03 -8.28
2024-05-02 -7.88
2024-05-01 -6.74
2024-04-30 -6.36
2024-04-29 -6.44
2024-04-26 -6.37
2024-04-25 -5.64
2024-04-24 -6.24
2024-04-23 -6.71
2024-04-22 -6.81
2024-04-19 -7.01
2024-04-18 -7.87
2024-04-17 -10.18
2024-04-16 -10.46
2024-04-15 -10.47
2024-04-12 -10.73
2024-04-11 -11.11
2024-04-10 -10.62
2024-04-09 -10.97
2024-04-08 -10.73
2024-04-05 -11.33
2024-04-04 -11.37
2024-04-03 -11.34
2024-04-02 -11.38
2024-04-01 -11.67
2024-03-28 -12.22
2024-03-27 -12.50
2024-03-26 -12.35
2024-03-25 -12.63
2024-03-22 -12.74
2024-03-21 -13.62
2024-03-20 -13.29
2024-03-19 -13.02
2024-03-18 -12.67
2024-03-15 -12.70
2024-03-14 -12.43
2024-03-13 -12.87
2024-03-12 -12.47
2024-03-11 -13.06
2024-03-08 -13.40